Evaluation of the Effect of SURGICEL® Powder in TKA

PHASE4RecruitingINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

September 28, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

September 30, 2025

Conditions
Knee Osteoarthritis
Interventions
DRUG

SURGICEL® Powder

SURGICEL® Powder are hemostatic product made of compacted, regenerated oxidized cellulose fine fiber aggregates, produced using a patented process. These particles are pre-loaded into an applicator device for application to the target bleeding site. SURGICEL® Powder are white with a slight yellow tint and have a faint caramel-like scent.When SURGICEL® Powder are fully saturated with blood, they expand into a brown or black gel-like substance that helps form a blood clot. This substance acts as a hemostatic adjunct to control localized bleeding.

Trial Locations (1)

100181

RECRUITING

Peking University Third Hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER